M. Thomas (Birmingham, United Kingdom), R. Ong-Salvador (Amsterdam, Netherlands)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Does smoking history change depending on the way questions are asked? D. Schuermans (Brussel, Belgium), S. De Bontridder (Brussel, Belgium), S. Hanon (Brussel, Belgium), E. Vanderhelst (Brussel, Belgium)
|   |
Impact on spirometry quality results when using 2005 or 2019 ATS/ERS guidelines E. Topole (Parma, Italy), S. Biondaro (Parma, Italy), I. Montagna (Parma, Italy), S. Corre (Parma, Italy), S. Stanojevic (Dalhousie, Canada), N. Das (Leuven, Belgium), K. Ray (Leuven, Belgium), M. Topalovic (Leuven, Belgium)
|   |
Long-term accuracy of DLCO devices M. Hegewald (Murray, United States of America), R. Jensen (Murray, United States of America), C. Buess (Zurich, Switzerland)
|  |
Evaluation of the Air Next spirometer in paediatric cystic fibrosis patients. N. Blyth (Leicester, United Kingdom), P. Patel (Leicester, United Kingdom), J. Madge (Leicester, United Kingdom), H. Lambert (Leicester, United Kingdom), M. Ahmed (Leicester, United Kingdom), E. Gaillard (Leicester, United Kingdom)
|   |
ArtiQ.QC facilitates spirometry quality control in asthma and COPD clinical trials E. Topole (Parma, Italy), S. Biondaro (Parma, Italy), I. Montagna (Parma, Italy), S. Corre (Parma , Italy), S. Stanojevic (Dalhousie, Canada), N. Das (Leuven, Belgium), K. Ray (Leuven, Belgium), M. Topalovic (Leuven, Belgium)
|   |
Impact of exercise training on pulmonary diffusing capacity in diabetes C. Scoubeau (Bruxelles, Belgium), E. Maufroy (Bruxelles, Belgium), C. Tordeur (Bruxelles, Belgium), V. Faoro (Bruxelles, Belgium)
|  |
Pulmonary function in patients with sporadic lymphangioleiomyomatosis. A. Cherniak (Moscow, Russian Federation), M. Makarova (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation)
|   |
A systematic review of the quality and fit of local spirometry studies to the Global Lung Initiative (GLI) and global chronic respiratory disease burden D. Prinsloo (Townsville (QLD), Australia), G. Nolan (Townsville (QLD), Australia), N. Pyne (Townsville (QLD), Australia), S. Munns (Townsville (QLD), Australia)
|   |
Medical rehabilitation of patients after COVID-19 and its impact on lung function and quality of life. O. Savushkina (Moscow, Russian Federation), A. Cherniak (Moscow, Russian Federation), M. Malashenko (Moscow, Russian Federation), E. Kryukov (St. Petersburg, Russian Federation)
|   |
The acceptability criterion for the difference between the forced inspiratory vital capacity (FIVC) and the forced vital capacity (FVC) are too strict? M. Chushkin (Moscow, Russian Federation), L. Popova (Moscow, Russian Federation), E. Shergina (Moscow, Russian Federation), A. Egorova (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation)
|   |
Is COPD Assessment Test score better correlated with airflow limitation or Hyperinflation? S. Khaldi (Ariana, Tunisia), K. Kchaou (Ariana, Tunisia), A. Chaker (Ariana, Tunisia), S. Mokaddem (Ariana, Tunisia), S. Ben Khamsa Jameleddine (Ariana, Tunisia)
|   |
Utility of predischarge spirometry in AECOPD discharges S. Naik (Harlow (Essex), United Kingdom), R. Ragatha (Harlow (Essex), United Kingdom), M. Anwar (Harlow (Essex), United Kingdom), J. Seigel (Harlow (Essex), United Kingdom)
|   |
The within session repeatability of spirometry parameters in patients with chronic obstructive pulmonary diseases M. Chushkin (Moscow, Russian Federation), L. Popova (Moscow, Russian Federation), E. Shergina (Moscow, Russian Federation), A. Egorova (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation)
|   |
Prevalence of altering selected spirometry maneuvers in asthma clinical trials. C. Mottram (Rochester, United States of America), G. Sowman (Buckingham, United Kingdom)
|   |
Impacts of transitioning to Global Lung Function Initiative (GLI) spirometry reference ranges on airflow classification and severity in Papua New Guinea. S. Taufa (Port Moresby, Papua New Guinea), S. Munns (Townsville, Australia)
|   |
The association of body mass index with lung function in patients treated for pulmonary tuberculosis L. Popova (Moscow, Russian Federation), M. Chushkin (Moscow, Russian Federation), E. Shergina (Moscow, Russian Federation), V. Beketova (Moscow, Russian Federation), A. Egorova (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation)
|   |
Effect of professional football practice on Maximal Inspiratoryand Expiratory Pressures A. Chaker (Ariana, Tunisia), S. Khaldi (Tunis, Tunisia), S. Chakroun (ariana, Tunisia), K. Kchaou (sfax, Tunisia), S. Ben Khamsa Jameleddine (Ariana, Tunisia)
|   |